J Shanghai Jiaotong Univ Sci

Journal of Shanghai Jiaotong University(Science) >

2021 , Vol. 26 >Issue 1: 25 - 32

DOI: https://doi.org/10.1007/s12204-021-2257-9

Medicine-Engineering Interdisciplinary Research

Brief ICF Core Set for Obstructive Pulmonary Diseases: Validation from the Perspective of Chinese Respiratory Physicians

Expand
  • (1. Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of
    Medicine, Shanghai 200025, China; 2. Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine,
    Shanghai 200025, China; 3. Department of Rehabilitation Medicine, the Seventh Affiliated Hospital of Sun Yat-sen
    University, Shenzhen 518107, Guangdong, China; 4. Guangdong Engineering and Technology Research Center for
    Rehabilitation Medicine and Translation, Shenzhen 518107, Guangdong, China)

Online published: 2021-01-19

Fold

Abstract

 Obstructive pulmonary diseases (OPDs) are the leading causes of mortality and disability worldwide. The International Classification of Functioning, Disability and Health (ICF) provides a framework for systematically assessing functioning and disability in patients with chronic diseases. To date, the ICF core sets for OPDs have not been validated by respiratory physicians in China’s mainland. This study was aimed at validating the briefICF core set for OPDs from the perspective of Chinese respiratory physicians. A three-round, consensus-building survey was conducted with Chinese respiratory physicians from Shanghai, Jiangsu, and Zhejiang from December 2 to December 16, 2017, using the Delphi technique. Their answers were analyzed for consensus degree. In this study, 52 experts (about 67.3% men) with a mean working experience of (19.3 ± 6.3) years completed the consensus process. After 3 rounds, the following 13 ICF categories were considered crucial for the assessment of OPDs, with an agreement of over 70%: 4 in body functions (b410-heart functions, b440-respiratory functions, b455-exercise tolerance functions, and b460-sensations associated with cardiovascular and respiratory functions), 2 in body structures (s410-structure of cardiovascular system, and s430-structure of respiratory system), 4 in activities and participation ( d230-carrying out daily routine, d450-walking, d455-moving around, and d640-doing housework), and 3 in environmental factors (e110-products or substances for personal consumption, e225-climate, and e260-air quality). Twelve (70.6%) categories in the current brief ICF core set were validated, and one additional category, b410-heart functions, was added. In conclusion, Chinese respiratory physicians largely supported the current brief ICF core set for OPDs. However, the newly added and unconfirmed categories need further investigation.

Key words： obstructive pulmonary diseases (OPDs); ICF core sets; validation; Chinese respiratory physician

Cite this article

LIU Bing (刘冰), WANG Pu (王朴), ZHOU Min (周敏), GUO Yi (过依), DAI Ranran (戴然然) . Brief ICF Core Set for Obstructive Pulmonary Diseases: Validation from the Perspective of Chinese Respiratory Physicians[J]. Journal of Shanghai Jiaotong University(Science), 2021 , 26(1) : 25 -32 . DOI: 10.1007/s12204-021-2257-9

References

[1] JAMES S L, ABATE D, ABATE K H, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990—2017: A systematic analysis for the Global Burden of Disease Study 2017 [J]. The Lancet, 2018, 392(10159): 1789-1858.
[2] ROTH G A, ABATE D, ABATE K H, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980—2017: A systematic analysis for the Global Burden of Disease Study 2017 [J]. The Lancet, 2018, 392(10159):1736-1788.
[3] Global Initiative for Chronic Obstructive Lung Disease.Global strategy for the diagnosis, management,and prevention of chronic obstructive pulmonary disease (2020 report) [EB/OL]. [2020-04-19].https://goldcopd.org/gold-reports/.
[4] Global Initiative for Asthma. Global strategy for asthma management and prevention (updated 2020)[EB/OL]. [2020-04-19]. https://ginasthma.org/ginareports/.
[5] FIGUEIREDO D, GABRIEL R, J′ACOME C, et al. Caring for relatives with chronic obstructive pulmonary disease: How does the disease severity impact on family carers? [J]. Aging & Mental Health, 2014,18(3): 385-393.
[6] VANFLETEREN L E G W, SPRUIT M A,WOUTERS E F M, et al. Management of chronic obstructive pulmonary disease beyond the lungs [J]. The Lancet Respiratory Medicine, 2016, 4(11): 911-924.
[7] MIRAVITLLES M, SORIANO J, GARC′IA-R′IO F, et al. Prevalence of COPD in Spain: Impact of undiagnosed COPD on quality of life and daily life activities [J]. Thorax, 2009, 64(10): 863-868.
[8] SVEDSATER H, ROBERTS J, PATEL C, et al. Life impact and treatment preferences of individuals with asthma and chronic obstructive pulmonary disease:Results from qualitative interviews and focus groups[J]. Advances in Therapy, 2017, 34(6): 1466-1481.
[9] CERNIAUSKAITE M, QUINTAS R, BOLDT C, et al. Systematic literature review on ICF from 2001 to 2009: Its use, implementation and operationalization[J]. Disability and Rehabilitation, 2011, 33(4): 281-309.
[10] STUCKI A, STOLL T, CIEZA A, et al. ICF Core Sets for obstructive pulmonary diseases [J]. Journal of Rehabilitation Medicine, 2004, 44(Suppl): 114-120.
[11] WEIGL M, CIEZA A, ANDERSEN C, et al. Identification of relevant ICF categories in patients with chronic health conditions: A Delphi exercise [J]. Journal of Rehabilitation Medicine, 2004, 44(Suppl): 12-21.
[12] HUANG J W, REINHARDT J D, DAI R R, et al. Validation of the brief international classification of functioning,disability, and health core set for obstructive
pulmonary disease in the Chinese context [J]. Chronic Respiratory Disease, 2019, 16: 1479973119843648.
[13] J′ACOME C, MARQUES A, GABRIEL R, et al.Chronic obstructive pulmonary disease and functioning:Implications for rehabilitation based on the ICF framework [J]. Disability and Rehabilitation, 2013,35(18): 1534-1545.
[14] MARQUES A, J′ACOME C, GABRIEL R, et al. Comprehensive ICF core set for obstructive pulmonary diseases:Validation of the activities and participation component through the patient’s perspective [J]. Disability and Rehabilitation, 2013, 35(20): 1686-1691.
[15] MARQUES A, J′ACOME C, GONC?ALVES A, et al.Validation of the comprehensive ICF core set for obstructive pulmonary diseases from the patient’s perspective [J]. International Journal of Rehabilitation Research, 2014, 37(2): 152-158.
[16] RAUCH A, KIRCHBERGER I, STUCKI G, et al. Validation of the comprehensive ICF core set for obstructive pulmonary diseases from the perspective of physiotherapists[J]. Physiotherapy Research International,2009, 14(4): 242-259.
[17] JOBST A, KIRCHBERGER I, CIEZA A, et al. Content validity of the comprehensive ICF core set for chronic obstructive pulmonary diseases: An international Delphi survey [J]. The Open Respiratory Medicine Journal, 2013, 7: 33-45.
[18] LAGE S M, J′ACOME C, OLIVEIRA A, et al. Validation of the International Classification of Functioning,Disability and Health Core Set for obstructive pulmonary diseases in the perspective of adults with asthma [J]. Disability and Rehabilitation, 2020, 42(1):86-92.
[19] HASSON F, KEENEY S, MCKENNA H. Research guidelines for the Delphi survey technique [J]. Journal of Advanced Nursing, 2000, 32(4): 1008-1015.
[20] CIEZA A, GEYH S, CHATTERJI S, et al. ICF linking rules: An update based on lessons learned [J]. Journal of Rehabilitation Medicine, 2005, 37(4): 212-218.
[21] EWERT T, FUESSL M, CIEZA A, et al. Identification of the most common patient problems in patients with chronic conditions using the ICF checklist [J]. Journal of Rehabilitation Medicine, 2004, 44(Suppl): 22-29.
[22] BHATT S P, DRANSFIELD M T. Chronic obstructive pulmonary disease and cardiovascular disease [J].Translational Research, 2013, 162(4): 237-251.
[23] WANNAMETHEE S G, SHAPER A G, PAPACOSTA O, et al. Lung function and airway obstruction: Associations with circulating markers of cardiac function and incident heart failure in older men—the British Regional Heart Study [J]. Thorax, 2016, 71(6): 526-534.
[24] PLEASANTS R A, OHAR J A, CROFT J B, et al.Chronic obstructive pulmonary disease and asthma—patient characteristics and health impairment [J].Journal of Chronic Obstructive Pulmonary Disease,2014, 11(3): 256-266.
[25] ONISHI K. Total management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular disease [J]. Journal of Cardiology,2017, 70(2): 128-134.
[26] CHARUSUSIN N, DACHA S, GOSSELINK R, et al.Respiratory muscle function and exercise limitation in patients with chronic obstructive pulmonary disease:A review [J]. Expert Review of Respiratory Medicine,2018, 12(1): 67-79.
[27] BARREIRO E, GEA J. Molecular and biological pathways of skeletal muscle dysfunction in chronic obstructive pulmonary disease [J]. Chronic Respiratory Disease,2016, 13(3): 297-311.
[28] COHEN A J, BRAUER M, BURNETT R, et al. Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: An analysis of data from the Global Burden of Diseases Study 2015[J]. The Lancet, 2017, 389(10082): 1907-1918.
[29] DEVRIES R, KRIEBEL D, SAMA S. Outdoor air pollution and COPD-related emergency department visits, hospital admissions, and mortality: A metaanalysis [J]. Journal of Chronic Obstructive Pulmonary Disease, 2017, 14(1): 113-121.
[30] TO T, ZHU J Q, LARSEN K, et al. Progression from asthma to chronic obstructive pulmonary disease (COPD). Is air pollution a risk factor? [J]. American Journal of Respiratory and Critical Care Medicine,2016, 194(4): 429-438.

Options
Outlines

/

〈 〉